Department of Pathology, Hong Kong Sanatorium & Hospital, Happy Valley, Hong Kong.
Ann Thorac Surg. 2010 Sep;90(3):e38-9. doi: 10.1016/j.athoracsur.2010.06.042.
We describe a 75-year-old Chinese man who presented with three separate tumors in three different lobes of the lung, without evidence of mediastinal or systemic involvement. All three tumors were surgically resected by minimal invasive approach. Based on a differing epidermal growth factor receptor (EGFR) mutation status, the tumors were characterized as synchronous triple primary rather than intrapulmonary metastases. This report highlights the clinical usefulness of molecular cancer biomarkers to determine prognosis and to guide management decision in multiple lung tumors.
我们描述了一位 75 岁的中国男性,他的肺部三个不同叶段分别呈现出三个独立的肿瘤,没有纵隔或全身累及的证据。所有三个肿瘤均通过微创方法进行了手术切除。基于不同的表皮生长因子受体(EGFR)突变状态,这些肿瘤被特征化为同步性三发性原发性肿瘤,而非肺内转移。本报告强调了分子癌症生物标志物在确定多个肺部肿瘤的预后和指导管理决策方面的临床应用价值。